CN106975069A - A kind of liver protecting composition and preparation method thereof - Google Patents
A kind of liver protecting composition and preparation method thereof Download PDFInfo
- Publication number
- CN106975069A CN106975069A CN201710302191.0A CN201710302191A CN106975069A CN 106975069 A CN106975069 A CN 106975069A CN 201710302191 A CN201710302191 A CN 201710302191A CN 106975069 A CN106975069 A CN 106975069A
- Authority
- CN
- China
- Prior art keywords
- parts
- liver protecting
- liver
- composition according
- count
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 66
- 210000004185 liver Anatomy 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title abstract description 16
- 239000000843 powder Substances 0.000 claims abstract description 37
- 210000000582 semen Anatomy 0.000 claims abstract description 21
- 240000008042 Zea mays Species 0.000 claims abstract description 20
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 20
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 19
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 19
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 19
- 244000197580 Poria cocos Species 0.000 claims abstract description 19
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 19
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 19
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 19
- 150000004676 glycans Chemical class 0.000 claims abstract description 19
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 19
- 239000005017 polysaccharide Substances 0.000 claims abstract description 19
- 241000628997 Flos Species 0.000 claims abstract description 18
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 18
- 235000005822 corn Nutrition 0.000 claims abstract description 18
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 18
- 244000241872 Lycium chinense Species 0.000 claims abstract description 17
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 17
- 239000000284 extract Substances 0.000 claims description 28
- 238000009472 formulation Methods 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 16
- 239000006187 pill Substances 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000003826 tablet Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- 239000002775 capsule Substances 0.000 claims description 9
- 239000007937 lozenge Substances 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 8
- 229940098465 tincture Drugs 0.000 claims description 8
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 235000013305 food Nutrition 0.000 claims description 5
- 244000273928 Zingiber officinale Species 0.000 claims description 4
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 4
- 235000008397 ginger Nutrition 0.000 claims description 4
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 3
- 239000006072 paste Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000007858 starting material Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 16
- 230000036541 health Effects 0.000 abstract description 6
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 239000003814 drug Substances 0.000 description 38
- 239000000463 material Substances 0.000 description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 229940079593 drug Drugs 0.000 description 12
- 239000000243 solution Substances 0.000 description 10
- 239000000126 substance Substances 0.000 description 9
- 239000002674 ointment Substances 0.000 description 7
- 239000000853 adhesive Substances 0.000 description 6
- 230000001070 adhesive effect Effects 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000003651 drinking water Substances 0.000 description 5
- 235000020188 drinking water Nutrition 0.000 description 5
- 239000007887 hard shell capsule Substances 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 208000007848 Alcoholism Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 201000007930 alcohol dependence Diseases 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 235000012907 honey Nutrition 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 241000237536 Mytilus edulis Species 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 3
- VZGDMQKNWNREIO-UHFFFAOYSA-N carbon tetrachloride Substances ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 239000013505 freshwater Substances 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 208000019423 liver disease Diseases 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 235000020638 mussel Nutrition 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000007901 soft capsule Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 239000000811 xylitol Substances 0.000 description 3
- 235000010447 xylitol Nutrition 0.000 description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 3
- 229960002675 xylitol Drugs 0.000 description 3
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 244000020551 Helianthus annuus Species 0.000 description 2
- 235000003222 Helianthus annuus Nutrition 0.000 description 2
- 206010067125 Liver injury Diseases 0.000 description 2
- 244000241838 Lycium barbarum Species 0.000 description 2
- 244000202052 Poncirus trifoliata Species 0.000 description 2
- 235000000404 Poncirus trifoliata Nutrition 0.000 description 2
- 241000219780 Pueraria Species 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 150000005693 branched-chain amino acids Chemical class 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000013583 drug formulation Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000007902 hard capsule Substances 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 231100000753 hepatic injury Toxicity 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000013547 stew Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- HOMSOWZTBJWNHP-UHFFFAOYSA-N 5-chlorothiadiazole Chemical compound ClC1=CN=NS1 HOMSOWZTBJWNHP-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 241000237519 Bivalvia Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 244000205754 Colocasia esculenta Species 0.000 description 1
- 235000006481 Colocasia esculenta Nutrition 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 244000058871 Echinochloa crus-galli Species 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 241000405398 Hovenia Species 0.000 description 1
- 235000008586 Hovenia Nutrition 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 241000382840 Hyriopsis cumingii Species 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 229920001491 Lentinan Polymers 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000002075 anti-alcohol Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036983 biotransformation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 231100000481 chemical toxicant Toxicity 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000035613 defoliation Effects 0.000 description 1
- 235000021185 dessert Nutrition 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000019581 fat taste sensations Nutrition 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 235000014304 histidine Nutrition 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229940115286 lentinan Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 150000002669 lysines Chemical class 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 229940042126 oral powder Drugs 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- VDYCLYGKCGVBHN-UHFFFAOYSA-N pachymaic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C VDYCLYGKCGVBHN-UHFFFAOYSA-N 0.000 description 1
- SRDNLMOBFKJOSD-UHFFFAOYSA-N pachymic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C(O)=O)C(O)CC21C SRDNLMOBFKJOSD-UHFFFAOYSA-N 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000005195 poor health Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 235000020795 whole food diet Nutrition 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Abstract
The present invention relates to field of health care products, in particular to a kind of liver protecting composition and preparation method thereof.Count by weight, the composition includes following component:0.05~0.4 part of 1~5 part of hoveniae semoveniae semen, 0.5~4 part of the root of kudzu vine, 0.5~4 part of the fruit of Chinese wolfberry, 0.1~3 part of Poria cocos, 0.1~3 part of corn oligopeptide powder, 0.5~1 part of swan-mussel polysaccharide and FLOS CHRYSANTHEMI ALBA from Haizhou of China.Described composition has liver-protective effect, without obvious toxic side effect, and has quick Dealcoholic sobering-up function concurrently.
Description
Technical field
The present invention relates to field of health care products, in particular to a kind of liver protecting composition and preparation method thereof.
Background technology
Liver is an organ based on metabolism in body, and plays deoxidation, storage glycogen inside body, divides
The roles such as the synthesis of secreting property protein.Meanwhile, liver to ex vivo and external for example various medicines of many non-nutritive substances,
Poisonous substance and in vivo some metabolites, with biotransformation, are thoroughly decomposed them or with original shape by metabolism
Excrete, this effect is also referred to as " function of detoxification ".
The living environment and mode of modern are highly detrimental to the health of liver, and it is homely food to stay up late, work overtime, take medicine,
It is improper diet etc., the health of liver is all directly endangered, in recent years virus hepatitis, liver fibrosis, fatty liver, alcoholic liver
The hepatopathys such as lesion, medicamentous liver lesion and liver cancer increasingly become the principal disease for threatening compatriots' health.Various hepatopathys and hepatopathy
The characteristics of sustainable growth and rejuvenation is presented in early stage patient, and market demand one kind is easy to use, have no toxic side effect and eutherapeutic
Health-care liver protecting product.
In view of this, it is special to propose the present invention.
The content of the invention
The first object of the present invention is to provide a kind of liver protecting composition, described combination for above-mentioned technical problem
Dirty effect is protected in thing tool liver protection, without obvious toxicity, also has quick Dealcoholic sobering-up function concurrently, and can mitigate drunk rear gasteremphraxis
Nausea and vomiting, feel dizzy.
The liver protecting composition of the present invention, is counted by weight, including following component:
1~5 part of hoveniae semoveniae semen, 0.5~4 part of the root of kudzu vine, 0.5~4 part of the fruit of Chinese wolfberry, 0.1~3 part of Poria cocos, corn oligopeptide powder 0.1
0.05~0.4 part of~3 parts, 0.5~1 part of swan-mussel polysaccharide and FLOS CHRYSANTHEMI ALBA from Haizhou of China.
The second object of the present invention is the method that offer prepares the present composition.
In one embodiment, each raw material is crushed, mixed.
In one embodiment, method of the invention comprises the following steps:
(a) each starting material with water is decocted, obtains decocting liquid, or extracted with ethanol water, obtain extract solution;
(b) formulation needed for being prepared with the decocting liquid or the extract solution.
Compared with prior art, beneficial effects of the present invention are:
(1) good drug efficacy, pure Chinese medicine formula, without obvious toxicity;
(2) convenient to take with Chinese medicine preparation form medication, effect is good;
(3) it is not only to relieve the effect of alcohol, moreover it is possible to reaching long-term protect liver, the mesh of liver protection.
Brief description of the drawings
, below will be to specific in order to illustrate more clearly of the specific embodiment of the invention or technical scheme of the prior art
The accompanying drawing used required in embodiment or description of the prior art is briefly described, it should be apparent that, in describing below
Accompanying drawing is some embodiments of the present invention, for those of ordinary skill in the art, before creative work is not paid
Put, other accompanying drawings can also be obtained according to these accompanying drawings.
Fig. 1 is the experimental result of experimental example 1 of the present invention;
Fig. 2 is the experimental result of experimental example 2 of the present invention.
Embodiment
One aspect of the present invention is related to a kind of liver protecting composition, is mainly made up of following raw material:Hoveniae semoveniae semen, the root of kudzu vine, Chinese holly
Matrimony vine, Poria cocos, corn oligopeptide powder, swan-mussel polysaccharide and FLOS CHRYSANTHEMI ALBA from Haizhou of China.
Count by weight, including following component:
1~5 part of hoveniae semoveniae semen, 0.5~4 part of the root of kudzu vine, 0.5~4 part of the fruit of Chinese wolfberry, 0.1~3 part of Poria cocos, corn oligopeptide powder 0.1
0.05~0.4 part of~3 parts, 0.5~1 part of swan-mussel polysaccharide and FLOS CHRYSANTHEMI ALBA from Haizhou of China.
It is preferred that, liver protecting composition as described above is counted by weight, including following component:
2~4 parts of hoveniae semoveniae semen, 1~3.5 part of the root of kudzu vine, 1~3.5 part of the fruit of Chinese wolfberry, 0.5~2.5 part of Poria cocos, corn oligopeptide powder
0.1~0.3 part of 0.5~2.5 part, 0.6~0.9 part of swan-mussel polysaccharide and FLOS CHRYSANTHEMI ALBA from Haizhou of China.
It is preferred that, liver protecting composition as described above is counted by weight, including following component:
2.5~3.5 parts of hoveniae semoveniae semen, 1.5~3 parts of the root of kudzu vine, 1.5~3 parts of the fruit of Chinese wolfberry, 1~2 part of Poria cocos, corn oligopeptide powder 1
0.15~0.25 part of~2 parts, 0.7~0.8 part of swan-mussel polysaccharide and FLOS CHRYSANTHEMI ALBA from Haizhou of China.
It is preferred that, liver protecting composition as described above is counted by weight, including following component:
3 parts of hoveniae semoveniae semen, 2.7 parts of the root of kudzu vine, 2.7 parts of the fruit of Chinese wolfberry, 1.5 parts of Poria cocos, 1.5 parts of corn oligopeptide powder, swan-mussel polysaccharide
0.75 part and 0.2 part of FLOS CHRYSANTHEMI ALBA from Haizhou of China.
It is preferred that, liver protecting composition as described above is counted by weight, and the composition also includes dried thin mushroom 1
~5 parts;More preferably 2~4 parts.
It is preferred that, liver protecting composition as described above is counted by weight, and the composition also includes ginger 0.05
~0.4 part;More preferably 0.1~0.3 part.
First, raw material (component)
Hoveniae semoveniae semen also known as cockspur, honey raisin tree is being dried to for Rhamnaceae plant trifoliate orange Dulcis (Hovenia duleis Thunb.)
Ripe seed, mild-natured, sweet acid is nontoxic, and its primary efficacy is reducing fever and causing diuresis, relieving restlessness of quenching the thirst, relieving alcoholism.For pyreticosis polydipsia,
Hiccup, vomits, difficult urination, the symptom such as alcoholism.Claim in motherland's Medical monographs, hoveniae semoveniae semen is mild-natured, sweet acid, enters spleen, lung
Two warps, cure mainly drunk, dysphoria with smothery sensation, thirsty, vomiting, difficulty in urination and defecation, have significant diuresis except wine poison effect, are that one kind is relieved the effect of alcohol good medicine.
Modern medicine study shows that hoveniae semoveniae semen is containing glucose, fructose, potassium nitrate, peroxidase etc..Hoveniae semoveniae semen and its compound can be significantly
The concentration of ethanol in blood is reduced, promotes the removing of ethanol, the excessive free radicals produced in vivo after drinking are eliminated, peroxidating is hindered
The formation of lipid, so as to mitigate damage of the ethanol to hepatic tissue, it is to avoid various metabolic disorders caused by alcoholism, induction it is each
Plant disease.In addition, trifoliate orange Ju or digestion human body cross the health fruit of fattiness, often eating can be with defatting beauty.
The root of kudzu vine is the dry root of the perennial defoliation liana Pueraria lobota of pulse family (Pueraria lobata (ffilld) Ohw1.),
Belong to Ministry of Public Health's announcement is both food and the article of medicine.《Bencao Shiyi》Call its " relieving alcoholism ".Modern study shows, Pueraria lobota
Root contains a variety of mineral matters needed by human, amino acid, vitamin and flavones etc., dynamic with treatment cardiovascular and cerebrovascular disease, prevention
The multiple pharmacological effects such as arteries and veins hardening, anti-oxidant, Antialcoholic liver-protecting.
The fruit of Chinese wolfberry is the dry mature fruit of plant of Solanaceae lycium barbarum (Lycuim barb arum L), as traditional
Integration of drinking and medicinal herbs material, is the traditional rare traditional Chinese medicine of China, " red treasured " laudatory title is have, rich in plant polyose, protein, vitamin
Etc. nutritional ingredient, the effect of with " nourishing yin and supplementing blood, benefiting shrewd head ", it has nourishing liver and kidney, benefiting shrewd head, blood-nourishing, and enhancing is exempted from
Epidemic disease power etc. is acted on.
Poria cocos alias Fu spirits, put down, sweet, light, the thoughts of returning home, spleen, kidney channel.Clearing damp and promoting diuresis, spleen-benefiting mind-tranquilizing.Chemical composition:Containing Poria cocos
Sugar, pachymic acid, protein, fat, lecithin, histidine, choline, ergosterol and sylvite etc..Belong to integration of drinking and medicinal herbs kind, have
There is spleen-benefiting mind-tranquilizing.
Maize oligopeptide is the small molecule that the zein extracted from wholefood corn is obtained by zymolysis technique
Peptide material, contains the hydrophobic amino acids such as a high proportion of leucine, valine, alanine and branched-chain amino acid and neutral amino
Acid, seldom containing basic amino acids such as lysines.This special acid composition so that maize oligopeptide has a variety of functions,
Such as hypotensive, relieve the effect of alcohol, reduce serum cholesterol.
Swan-mussel polysaccharide (Hyriopsis cumingii polysacchride) is from Non-marine Bivalvess mollusk triangle
A kind of white powder natural polysaccharide material obtained from extraction, purifying in the freshwater mussel meat of sail freshwater mussel.Its research is shown, freshwater mussel meat is more
Sugar has obviously protective effect to stem cell injuries.
FLOS CHRYSANTHEMI ALBA from Haizhou of China is also known as camomile, is the traditional cultivation medicinal plant of China.Proved through modern pharmacology:It has stop dysentery, disappeared
Inflammation, improving eyesight, decompression, lipid-loweringing, the effect of salubrity.Its Central nervous has sedation, and has refrigeration function.
Mushroom is nutritious, delicious flavour, have " king in mushroom ", the laudatory title of " hats of vegetables ".It is sweet, it is mild-natured.Return liver,
Stomach.Rich in branched-chain amino acid, hepatic injury is promoted to recover.Rich in lentinan, toxic chemical substance can be significantly reduced and resisted
Infringement to liver.Rich in the nutritional ingredients such as B family vitamin, various trace elements, protect liver, liver protection.
Ginger is pungent, slightly warm in nature.Return lung, the spleen channel.For warm stomach, invigorating the spleen.
2nd, form and formulation
The composition that the present invention is provided can both be taken orally as medicine, can also be carried out as health food or beverage
It is edible.
In one embodiment, composition of the invention is simple mixtures.Preparation process is by each raw material) it is simple mixed
Conjunction.
In another embodiment, composition of the invention can be made into the form of Chinese patent drug.The formulation of Chinese patent drug
Including but not limited to pill, powder, paste, tablet, granule (electuary), lozenge, capsule, aqua, tincture.
(1) pill
Pill is fine medicinal material powder or medicinal substances extract plus suitable binders or auxiliary material, the spherical or spherical solid being made
Preparation, is one of Chinese patent drug most ancient formulation.It is divided into honeyed bolus, water-honeyed pill, the water-bindered pill, paste again according to the different pills of adhesive
The types such as ball, condensed pill, micropill.
Preferably use condensed pill.Condensed pill is the decocting liquid or extract solution of whole medicinal materials or part medicinal material, with suitable auxiliary material
Or fine drug powder adds suitable adhesive to be made.According to the difference of adhesive, concentration honeyed bolus, the concentration water-bindered pill, condensed water are divided into again
Honeyed bolus.Condensed pill small volume, effective ingredient content is high, it is easy to takes, absorptance is dissolved in vivo slower.
In a preferred embodiment, by whole medicinal materials or the decocting liquid or extract solution of part medicinal material, with auxiliary material or medicine
Thing fine powder adds adhesive that condensed pill is made.Preferably, by whole medicinal material decocting liquids or extract solution and adhesive and optional auxiliary material system
Into condensed pill.
(2) powder
Powder is the powder preparation that one or more medicinal materials are mixed, and point oral powder and external pulvis, are China
One of ancient times formulation.Powder therapeutic domain is wide, disperses fast after taking, and proves effective rapid, and with easy to make, easy to carry, section
The advantages of saving medicinal material.
(3) paste
One of paste system pharmaceutical dosage form.Paste is the formulation that medicine is decocted to concentration with water or vegetable oil.Have for oral administration
With two kinds of external application.Cream for oral administration generally shunts medicinal extract, medicinal extract, three kinds of soft extracts again;External plaster has two kinds of ointment, plaster.Wherein take orally
Soft extracts and externally-applied ointment are common formulations in paste.Soft extracts for oral administration is called cream taste, is that medicine is added water to decoct, and filters dregs, plus
Enter rock sugar, honey etc., be boiled into the cream of stiff, can long-term taking.It is usually used in chronic disease or person in poor health.The ointment of external application claims
Ointment, general ointment is that beeswax is added in cotton seed oil or peanut oil, and heating fusing multiplies the fine drug powder that heat adds application, no
Disconnected stirring, to be condensed.The readily volatilized medicine such as borneol, camphor, can add after ointment is cold and stir evenly.External-applied ointment is typically used
In outer painting skin ulcer mange etc..
Present invention preferably uses soft extract, soft extract (cream taste) is that medicinal material is boiled with decocting, after concentration of removing slag, plus sweetener system
Into semisolid preparation, also known as cream grow.Sweetener can be refined honey or sugar, xylitol, preferably xylitol.Soft extract, which has, to be absorbed
It hurry up, concentration is high, small volume, be easy to preserve, the characteristics of can taking the standby long period.There is nourishing conditioning, it is slow for treating
Venereal disease and weakness due to chronic disease person.
(4) tablet
Tablet is the Formulation that fine medicinal material powder or extract are suppressed with suitable auxiliary material or fine medicinal material powder, sub-dip cream
Piece, semi-extract tablets and full powder piece etc., are one of conventional modern formulations.Tablet volume is small, and consumption is accurate, and easy disintegrating comes into force soon,
And with production efficiency is high, cost is low, take and the convenient advantage of accumulating.Tablet is applied to various diseases.The present invention preferably makes
Use medicinal extract piece.
(5) granule
Granule (electuary) be medicinal substances extract with suitable auxiliary material or with the granular formulations that fine medicinal material powder is made, be
The novel form grown up on the basis of decoction, powder and syrup.There is graininess and block two kinds, be divided into soluble, suspension
The different type such as property, effervescency and sugar-containing type, Sugarless type.Granule small volume, it is lightweight, take simple, it is in good taste, act on fast
Speed, is used for the medicine of the effects such as help, cough-relieving, heat-clearing.
Preferably, prepared during preparation using water extract (decocting liquid).
(6) lozenge
Lozenge is fine medicinal material powder and suitable amount of adhesive such as honey, glutinous rice flour or regulation shape is made using the viscosity of medicinal material in itself
The solid pharmaceutical preparation of shape.For oral administration or external application is available for, effect is taken orally and is approached with starched pill, external application applies affected part after using water or vinegar mill juice.
Holding in the mouth or the eyes is used lozenge type mostly.
Preferably, lozenge of the invention is lozenge for oral administration.
(7) capsule
Capsule includes hard capsule and soft capsule.
Hard capsule be by appropriate medicinal substances extract, medicinal substances extract dosing powder or auxiliary material be made uniform powder or
Grain, is filled in the formulation being made in hard shell capsules.It is mainly oral.Hard shell capsules outward appearance is neat and artistic, it is easy to swallow, and can cover medicine
The bad odor of thing, disintegration is fast, good absorbing.Suitable for photaesthesia, unstable or meet wet, thermally labile medicine, or there is spy
The medicine of different odor, or need the medicine of timing positioning release.Children, the medicine strong to gastric irritation should not be made
Capsule.
Soft capsule is by oils or is closed in capsule material to liquid medicine of the capsule materials such as gelatin without dissolution or suspension
The formulation being inside made.Feature is similar to hard shell capsules.Hard shell capsules and soft capsule are handled by proper method or with other medicinal high scores
Sub- material processing, makes softgel shell not dissolve in gastric juice, but is disintegrated discharge active component in intestinal juice, is capsulae enterosolubilis.
Preferably, capsule of the invention is that the medicinal substances extract for obtaining decocting liquid or extract solution adds auxiliary material that uniform powder is made
End or particle, are filled in the formulation being made in hard shell capsules.
(8) aqua
Aqua is the aqueous solution of Chinese medicine composition, and medicament is dispersed in water with lewis' acid state, medicament it is dense
Degree is depending on the water solubility of active compound, and ordinary circumstance is its maxima solubility, is watered dilution when using again.In order that obtaining in medicine
Active ingredient release it is complete, can be using the aqua prepared by method such as hot water is fried, fried number of times can for 1 time, 2 times or more
Repeatedly.
(9) tincture
Tincture is that the ethanol of medicine normal concentration leaches or dissolved the supernatant liquid preparation being made, and can also use liquid extract
Dilution is made.It is divided to for oral administration and two kinds of external application.Tincture is prepared without heating, and composition is purer, and active constituent content is high, and dosage is accurate
Really, absorb rapid, be suitable for preparing the preparation containing volatile ingredient or thermo-labile component.Preferably, tincture of the invention is
Tincture for oral administration.
3rd, purposes
One aspect of the present invention is related to purposes of the composition of the present invention in preparing for liver protecting medicine.
The Foods or drinkses containing composition as described above are also claimed in another aspect of the present invention.
The food includes snack, dessert, raw material (stock), soup, stew (stew), sauce or gravy etc..
4th, preparation method
Another aspect of the present invention is related to the preparation method of liver protecting composition.
1st, the preparation of simple mixtures
Above-mentioned raw materials can be simply mixed together, so as to prepare the simple mixtures of the present invention.
In one embodiment, the method for preparing said composition comprises the following steps:Each component is crushed, one is blended in
Rise.
2nd, the preparation of Chinese patent drug
In one embodiment, the method for preparing the present composition comprises the following steps:
(a) above-mentioned raw materials are boiled with decocting, obtains decocting liquid, or extracted with ethanol water, obtain extract solution;
(b) formulation needed for being prepared with decocting liquid.
Formulation can be above-mentioned formulation, for example pill, powder, paste, tablet, granule (electuary), lozenge, capsule,
Aqua or tincture.
It is of course also possible to take Chinese patent drug formulation.On the basis of above-mentioned decocting liquid dosage, Chinese patent drug formulation dose passes through
Clinical trial in the art can be determined.
Embodiment of the present invention is described in detail below in conjunction with embodiment, but those skilled in the art will
Understand, the following example is merely to illustrate the present invention, and is not construed as limiting the scope of the present invention.It is unreceipted specific in embodiment
Condition person, the condition advised according to normal condition or manufacturer is carried out.Agents useful for same or the unreceipted production firm person of instrument, be
The conventional products that can be obtained by commercially available purchase.
Embodiment 1
Hoveniae semoveniae semen 5g, root of kudzu vine 4g, fruit of Chinese wolfberry 0.5g, Poria cocos 3g, swan-mussel polysaccharide 1g and FLOS CHRYSANTHEMI ALBA from Haizhou of China 0.05g.
Add 1.5 liters of drinking water pots to boil 60 minutes, be then concentrated into paste, mix, be fabricated to corn oligopeptide powder 3g
Ball.
Embodiment 2
Hoveniae semoveniae semen 2g, root of kudzu vine 3.5g, fruit of Chinese wolfberry 1g, Poria cocos 2.5g, corn oligopeptide powder 0.5g, swan-mussel polysaccharide 0.9g and
FLOS CHRYSANTHEMI ALBA from Haizhou of China 0.1g.
Add 1.5 liters of drinking water pots to boil 60 minutes, then concentrate, add xylitol, soft extract is made.
Embodiment 3
Hoveniae semoveniae semen 4g, root of kudzu vine 3.5g, fruit of Chinese wolfberry 3.5g, Poria cocos 0.5g, corn oligopeptide powder 2.5g, swan-mussel polysaccharide 0.6g with
And FLOS CHRYSANTHEMI ALBA from Haizhou of China 0.3g.
Add 1.5 liters of drinking water pots to boil 60 minutes, then concentrate, add dextrin mixing, suppress, dry, obtained tablet.
Embodiment 4
Hoveniae semoveniae semen 3.5g, root of kudzu vine 1.5g, fruit of Chinese wolfberry 1.5g, Poria cocos 2g, corn oligopeptide powder 1g, swan-mussel polysaccharide 0.8g and
FLOS CHRYSANTHEMI ALBA from Haizhou of China 0.15g.
Add 1.5 liters of drinking water pots to boil 40 minutes, be concentrated into 100mL, produce aqua.
Embodiment 5
Hoveniae semoveniae semen 2.5g, root of kudzu vine 3g, fruit of Chinese wolfberry 3g, Poria cocos 1g, corn oligopeptide powder 2g, swan-mussel polysaccharide 0.7g, FLOS CHRYSANTHEMI ALBA from Haizhou of China
0.25g and dried thin mushroom 5g.
Add 1.5 liters of drinking water pots to boil 40 minutes, be concentrated into 100mL, produce aqua.
Embodiment 6
Hoveniae semoveniae semen 3g, root of kudzu vine 2.7g, fruit of Chinese wolfberry 2.7g, Poria cocos 1.5g, corn oligopeptide powder 1.5g, swan-mussel polysaccharide 0.75g,
FLOS CHRYSANTHEMI ALBA from Haizhou of China 0.2g, dried thin mushroom 3g and ginger 0.2g.
Boil medicine in two times, add water 165ml for the first time, pot boiling 90min;Add water 125ml for the second time, pot boiling 60min, by 2 times
Decocting liquid merges, and is concentrated into 30ml, produces aqua.
Experimental example 1
Composition aqua made from Example 6 is used as cell toxicity test:
Cell is used:Chang Cell, dosage is equivalent to 0~8 bottle/day.Under conditions of cell survival rate >=90% i.e.
It is judged as nontoxicity.As a result as shown in table 1 and Fig. 1.
Table 1
As a result:Equivalent is taken under conditions of≤8 bottles/day, not show cytotoxicity.
Conclusion:Under conditions of normal bottle/day of dose 1~2, human body is had no toxic side effect.
Experimental example 2
Composition aqua is CCl made from Example 64Cause the Germicidal efficacy of acute liver:
60 mouse are randomly divided into 6 groups, Normal group 10, CCl4Model group 10, sample sets high, normal, basic each 10
Only, positive control (sunflower liver-protecting tablet) 10.Use olive oil CCl4Concentration is 1%, is noted according to 10ml/kg body weight abdominal cavity
Penetrate.After gastric infusion 1 week, CCl4Injection 0.1%CCl in model group and sample sets mouse peritoneal4Oil solution modeling.Every after 18h
Mouse takes blood with eye socket blood taking method, separates serum, and conventional method detection liver function index (ALT, AST) the results are shown in Table 2 and Fig. 2.
Table 2
Group | Number of animals | ALT(U/L) | AST(U/L) |
Blank group | 10 | 33.90±10.90** | 28.90±3.57** |
Contrast groups | 10 | 347.15±41.33** | 126.07±14.71** |
Model group | 10 | 484.51±93.39 | 143.43±24.78 |
Small dose group | 10 | 297.31±50.23** | 100.07±15.33** |
Middle dose group | 10 | 249.35±48.56** | 90.93±15.45** |
Heavy dose of group | 10 | 198.13±45.01** | 82.90±10.75** |
Positive group | 10 | 234.55±52.01** | 98.73±12.93** |
Note:Compared with model group, * P < 0.05, * * P < 0.01.
Wherein, blank group is without the mouse handled by acute liver damage;
Contrast groups use publication number CN102960809A, publication date on March 13rd, 2013, priority date December 5 in 2012
The anti-fatigue beverage that relieves the effect of alcohol used in the embodiment 5 of day;
Model group is the mouse for handling but being handled without any liver protection by acute liver damage;
The drug concentration that small dose group is taken is 810mg/kg;
The drug concentration that middle dose group is taken is 1620mg/kg;
The taken drug concentration of heavy dose group is 3240mg/kg;
Positive group is to take the mouse of sunflower liver-protecting tablet, and dose is 560mg/kg.
Three dosage of this sample can reduce ALT vigor, be compared with model group, there is pole significant difference (P < 0.01);
Three dosage of this sample can reduce AST vigor, and three dosage groups are compared with model group, there is pole significant difference (P <
0.01).Experimental result illustrates that this sample has significant protective effect to hepatic injury, with obvious hepatoprotective effect.
Finally it should be noted that:Various embodiments above is merely illustrative of the technical solution of the present invention, rather than its limitations;To the greatest extent
The present invention is described in detail with reference to foregoing embodiments for pipe, but it will be understood by those within the art that:Its
The technical scheme described in foregoing embodiments can still be modified, or to which part or all technical characteristic
Carry out equivalent substitution;And these modifications or replacement, the essence of appropriate technical solution is departed from various embodiments of the present invention skill
The scope of art scheme.
Claims (10)
1. a kind of liver protecting composition, it is characterised in that count by weight, including following component:
1~5 part of hoveniae semoveniae semen, 0.5~4 part of the root of kudzu vine, 0.5~4 part of the fruit of Chinese wolfberry, 0.1~3 part of Poria cocos, corn oligopeptide powder 0.1~3
0.05~0.4 part of part, 0.5~1 part of swan-mussel polysaccharide and FLOS CHRYSANTHEMI ALBA from Haizhou of China.
2. liver protecting composition according to claim 1, it is characterised in that count by weight, including following component:
2~4 parts of hoveniae semoveniae semen, 1~3.5 part of the root of kudzu vine, 1~3.5 part of the fruit of Chinese wolfberry, 0.5~2.5 part of Poria cocos, corn oligopeptide powder 0.5~
0.1~0.3 part of 2.5 parts, 0.6~0.9 part of swan-mussel polysaccharide and FLOS CHRYSANTHEMI ALBA from Haizhou of China.
3. liver protecting composition according to claim 2, it is characterised in that count by weight, including following component:
2.5~3.5 parts of hoveniae semoveniae semen, 1.5~3 parts of the root of kudzu vine, 1.5~3 parts of the fruit of Chinese wolfberry, 1~2 part of Poria cocos, corn oligopeptide powder 1~2
0.15~0.25 part of part, 0.7~0.8 part of swan-mussel polysaccharide and FLOS CHRYSANTHEMI ALBA from Haizhou of China.
4. liver protecting composition according to claim 3, it is characterised in that count by weight, including following component:
3 parts of hoveniae semoveniae semen, 2.7 parts of the root of kudzu vine, 2.7 parts of the fruit of Chinese wolfberry, 1.5 parts of Poria cocos, 1.5 parts of corn oligopeptide powder, swan-mussel polysaccharide 0.75
0.2 part of part and FLOS CHRYSANTHEMI ALBA from Haizhou of China.
5. the liver protecting composition according to any one of Claims 1 to 4, it is characterised in that count by weight, described
Composition also includes 1~5 part of dried thin mushroom.
6. the liver protecting composition according to any one of Claims 1 to 4, it is characterised in that count by weight, described
Composition also includes 0.05~0.4 part of ginger.
7. liver protecting composition according to claim 1, it is characterised in that the formulation of the composition is pill, dissipated
Agent, paste, tablet, granule, lozenge, capsule, aqua or tincture.
8. prepare the method for the composition according to any one of claim 1~7, it is characterised in that comprise the following steps:Will
Each raw material is crushed, and is mixed.
9. prepare the method for the composition according to any one of claim 1~7, it is characterised in that comprise the following steps:
(a) each starting material with water is decocted, obtains decocting liquid, or extracted with ethanol water, obtain extract solution;
(b) formulation needed for being prepared with the decocting liquid or the extract solution.
10. the Foods or drinkses containing the composition described in any one of claim 1~7.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710302191.0A CN106975069B (en) | 2017-05-02 | 2017-05-02 | Liver-protecting composition and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710302191.0A CN106975069B (en) | 2017-05-02 | 2017-05-02 | Liver-protecting composition and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106975069A true CN106975069A (en) | 2017-07-25 |
CN106975069B CN106975069B (en) | 2021-01-08 |
Family
ID=59341805
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710302191.0A Active CN106975069B (en) | 2017-05-02 | 2017-05-02 | Liver-protecting composition and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106975069B (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107536016A (en) * | 2017-09-11 | 2018-01-05 | 北京盛德元健康科技有限公司 | A kind of cardioprotection and the nutraceutical for promoting liver health |
CN108771089A (en) * | 2018-06-06 | 2018-11-09 | 唐山肽景堂生物科技有限公司 | A kind of solid beverage and preparation method thereof for adjusting liver diseases peptide compounding |
CN109380633A (en) * | 2018-11-15 | 2019-02-26 | 湖北华龙西科生物科技有限公司 | A kind of biological nano selenium small molecule water drink with function and preparation method thereof |
CN109432386A (en) * | 2018-11-08 | 2019-03-08 | 武汉森澜生物科技有限公司 | A kind of corn peptide combinations of relieving alcoholism and protecting liver and preparation method thereof |
CN109601977A (en) * | 2018-08-07 | 2019-04-12 | 丽睿客信息科技(北京)有限公司 | The food that suitable hepatopath eats |
CN110448619A (en) * | 2018-05-08 | 2019-11-15 | 沈阳离坎生物科技有限公司 | It is a kind of to increase capacity for liquor and anti-intoxication composite preparation and preparation method thereof |
CN112535230A (en) * | 2020-11-12 | 2021-03-23 | 浙江英格莱制药有限公司 | Herbaceous plant corn peptide vitamin sugar pill and preparation method thereof |
CN114569686A (en) * | 2022-04-01 | 2022-06-03 | 河北科技大学 | Anti-alcohol composition, tablet with anti-alcohol effect and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102188469A (en) * | 2011-05-27 | 2011-09-21 | 河南大学 | Chrysanthemum morifolium extractive with live protection function, extraction method and applications thereof |
CN102845663A (en) * | 2012-09-12 | 2013-01-02 | 湖南千金养生坊健康品股份有限公司 | Health-care product composition with liver-protecting and hangover-alleviating functions |
CN102960809A (en) * | 2012-12-05 | 2013-03-13 | 上海普维健康食品有限公司 | Hangover alleviating beverage |
CN104524416A (en) * | 2014-12-26 | 2015-04-22 | 王元忠 | Pharmaceutical composition, and use and preparation method of pharmaceutical composition as well as medicine, food and/or health food prepared from pharmaceutical composition |
-
2017
- 2017-05-02 CN CN201710302191.0A patent/CN106975069B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102188469A (en) * | 2011-05-27 | 2011-09-21 | 河南大学 | Chrysanthemum morifolium extractive with live protection function, extraction method and applications thereof |
CN102845663A (en) * | 2012-09-12 | 2013-01-02 | 湖南千金养生坊健康品股份有限公司 | Health-care product composition with liver-protecting and hangover-alleviating functions |
CN102960809A (en) * | 2012-12-05 | 2013-03-13 | 上海普维健康食品有限公司 | Hangover alleviating beverage |
CN104524416A (en) * | 2014-12-26 | 2015-04-22 | 王元忠 | Pharmaceutical composition, and use and preparation method of pharmaceutical composition as well as medicine, food and/or health food prepared from pharmaceutical composition |
Non-Patent Citations (2)
Title |
---|
刘雪娇等人: ""玉米低聚肽对CCl4所致小鼠急性肝损伤的保护作用研究"", 《中国农业科技导报》 * |
张宁: ""香菇中的化学成分及相关应用的基础研究"", 《中国优秀硕士学位论文全文数据库 医药卫生科技辑》 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107536016A (en) * | 2017-09-11 | 2018-01-05 | 北京盛德元健康科技有限公司 | A kind of cardioprotection and the nutraceutical for promoting liver health |
CN107536016B (en) * | 2017-09-11 | 2021-01-12 | 北京盛德元健康科技有限公司 | A nutritional food for protecting heart and promoting liver health |
CN110448619A (en) * | 2018-05-08 | 2019-11-15 | 沈阳离坎生物科技有限公司 | It is a kind of to increase capacity for liquor and anti-intoxication composite preparation and preparation method thereof |
CN108771089A (en) * | 2018-06-06 | 2018-11-09 | 唐山肽景堂生物科技有限公司 | A kind of solid beverage and preparation method thereof for adjusting liver diseases peptide compounding |
CN109601977A (en) * | 2018-08-07 | 2019-04-12 | 丽睿客信息科技(北京)有限公司 | The food that suitable hepatopath eats |
CN109432386A (en) * | 2018-11-08 | 2019-03-08 | 武汉森澜生物科技有限公司 | A kind of corn peptide combinations of relieving alcoholism and protecting liver and preparation method thereof |
CN109380633A (en) * | 2018-11-15 | 2019-02-26 | 湖北华龙西科生物科技有限公司 | A kind of biological nano selenium small molecule water drink with function and preparation method thereof |
CN112535230A (en) * | 2020-11-12 | 2021-03-23 | 浙江英格莱制药有限公司 | Herbaceous plant corn peptide vitamin sugar pill and preparation method thereof |
CN114569686A (en) * | 2022-04-01 | 2022-06-03 | 河北科技大学 | Anti-alcohol composition, tablet with anti-alcohol effect and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN106975069B (en) | 2021-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106975069A (en) | A kind of liver protecting composition and preparation method thereof | |
US6416795B1 (en) | Herbal extract composition for stress prevention and treatment | |
US20040076641A1 (en) | Herbal dietary supplement | |
CN103229884A (en) | A curcumin healthy hard candy and a preparation method thereof | |
CN102178885B (en) | Medicinal composition for sobering | |
JP2003192605A (en) | Lipase inhibitant | |
CN103203008A (en) | Pharmaceutical composition for sobering up and preparation method thereof | |
JP6463504B2 (en) | Health supplements for hair growth promotion, hair loss relief and improvement, blood sugar control, gastrointestinal symptom relief and improvement | |
KR20190045057A (en) | Dietary herbal composition for improving obesity and method for producing the same | |
CN101658641A (en) | Health-care preparation containing gastrodia tuer, folium cortex eucommiae, and Ilex latifolia thumb and preparation method thereof | |
TW200841829A (en) | Instant tea | |
JP2007135493A (en) | Health food | |
KR20160000695A (en) | Herbal-medicine containing dha for recovering fatigue and enhancing memory, and method of manufacturing the same | |
JP3489095B2 (en) | Health foods and beverages | |
KR101618048B1 (en) | Choco pill with ultrafine gigantic angelica powder and manufacturing method thereof | |
KR101910013B1 (en) | A composition for improving, preventing and treating of pain comprising herb extract | |
KR20160014075A (en) | Cynanchi Wilfordii Tea and Manufacture Method thereof | |
KR101783549B1 (en) | Health supplement food containing dha for recovering fatigue, and method of manufacturing the same | |
JP2007131605A (en) | Indefinite complaint-improving composition and food | |
JP2004352626A (en) | Anticholesterol agent containing plant-derived component | |
CN113925172A (en) | Giant salamander peptide nutritional composition suitable for children | |
JP2004321087A (en) | Healthy food and method for producing the same | |
CN105685912A (en) | Lung-moistening cough-relieving honey containing citrus honey and lily honey | |
CN105685709A (en) | Healthcare solid beverage and method for preparing same | |
CN105167013A (en) | Health-care food product using hazelnut meal as raw material and preparation process thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |